United States Patent and Trademark Office

Octo Wins Spot on USPTO Intelligent Automation Innovation Support Services (IAISS) Blanket Purchase Agreement (BPA)

Tuesday, March 31, 2020 - 1:30pm

Octo today announced it has been awarded a spot on the United States Patent and Trademark Office (USPTO) Intelligent Automation Innovation Support Services (IAISS) blanket purchase agreement (BPA).

Key Points: 
  • Octo today announced it has been awarded a spot on the United States Patent and Trademark Office (USPTO) Intelligent Automation Innovation Support Services (IAISS) blanket purchase agreement (BPA).
  • Octo has focused attention on emerging technologies for over a decade, said Octo Executive Vice President Charlie McQuillan.
  • This opportunity allows us to bring the most current research and development to USPTO while continuing to support them with core services weve been providing since 2014.
  • We are excited to build on our current relationship and help move the agency forward through advanced innovation and automation.

IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals

Friday, March 27, 2020 - 12:30am

IGC filed this application for its IGC-504 formulation (#15/751,901) on August 11, 2016.

Key Points: 
  • IGC filed this application for its IGC-504 formulation (#15/751,901) on August 11, 2016.
  • A public copy of the patent is available on the USPTO website.
  • A patent for an invention is the grant of a property right to the inventor, issued by the USPTO.
  • The company is based in Maryland, U.S.A. Our website: www.igcinc.us .Twitter @IGCIR
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005803/en/

ProtoKinetix Files for Patent Protection for AAGP® to be Used in Dry Eye Disease

Thursday, March 19, 2020 - 1:00pm

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) recently filed for patent protection for new applications of its AAGP molecule.

Key Points: 
  • ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) recently filed for patent protection for new applications of its AAGP molecule.
  • Based on these results the company has filed for patent protection with the United States Patent and Trademark Office (USPTO) for the application of DED.
  • Dry Eye Disease is one of the most common ocular problems with an estimated prevalence of almost 5-million people over the age of fifty in the United States alone.
  • Current therapies for dry eye are palliative with a focus on the replacement of tears to reduce symptoms.

SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Nirogacestat, Extending Patent Protection into 2039

Wednesday, March 18, 2020 - 10:30am

The 087 patent is a composition of matter patent that covers the polymorphic form of nirogacestat that is currently in clinical development.

Key Points: 
  • The 087 patent is a composition of matter patent that covers the polymorphic form of nirogacestat that is currently in clinical development.
  • SpringWorks has exclusive rights to the 087 patent pursuant to an existing worldwide license with Pfizer.
  • We are very pleased that the USPTO has issued this patent, which builds upon our existing intellectual property portfolio and extends patent protection for nirogacestat to 2039, said Saqib Islam, Chief Executive Officer of SpringWorks.
  • In addition, SpringWorks is seeking to advance nirogacestat as a cornerstone of B-cell maturation antigen (BCMA) combination therapy in multiple myeloma.

Axonics® Announces Filing of Petitions Before the United States Patent and Trademark Office Contesting the Validity of Medtronic Patents

Monday, March 16, 2020 - 10:00am

The IPR petitions filed by Axonics concern the following Medtronic-owned patents: 8,036,756; 8,626,314; 7,774,069; 8,457,758; 8,738,148; 9,463,324 and 9,821,112.

Key Points: 
  • The IPR petitions filed by Axonics concern the following Medtronic-owned patents: 8,036,756; 8,626,314; 7,774,069; 8,457,758; 8,738,148; 9,463,324 and 9,821,112.
  • While this type of anticompetitive behavior from the incumbent is regrettable, as evidenced by this USPTO filing, we are ready and quite able to respond appropriately.
  • We believe that we have provided the USPTO compelling challenges to the validity of the Medtronic patents at issue and now await institution of each IPR petition.
  • In most circumstances, the USPTO will take six months to determine whether to institute an IPR after filing of the petition.

Aesthetics Biomedical Announces Issuance of U.S. Patent For Biologic Preserving Composition and Methods of Use

Wednesday, March 11, 2020 - 4:00pm

PHOENIX, March 11, 2020 /PRNewswire-PRWeb/ --Aesthetics Biomedical Inc, a company committed to the development and distribution of innovative aesthetic devices, products, and services for the global market, announces issuance of U.S. Patent for Biologic Preserving Composition and Methods of Use.

Key Points: 
  • PHOENIX, March 11, 2020 /PRNewswire-PRWeb/ --Aesthetics Biomedical Inc, a company committed to the development and distribution of innovative aesthetic devices, products, and services for the global market, announces issuance of U.S. Patent for Biologic Preserving Composition and Methods of Use.
  • The United States Patent and Trademark Office has issued Aesthetics Biomedical the U.S. Patent No.
  • The issuance of this patent comes just months after the company launched the proprietary SoME Skincare product.
  • This patent, further positions Aesthetics Biomedical's SoME Skincare brand at the forefront of innovation in the physician dispensed topical-use skincare product category.

DSI Rolls Out New AEON Vendor Portal

Monday, March 9, 2020 - 11:17pm

DSI's AEON Vendor Portal dramatically enhances the way USPTO engages with their vendor community by implementing faster and more efficient electronic invoicing, deliverable submission, status of payments, and tracking of awards.

Key Points: 
  • DSI's AEON Vendor Portal dramatically enhances the way USPTO engages with their vendor community by implementing faster and more efficient electronic invoicing, deliverable submission, status of payments, and tracking of awards.
  • "The AEON Vendor Portal is a major step in modernizing the way the federal government and vendor community interact with innovative technologies.
  • DSI worked closely with USPTO and their vendors to deploy the AEON Vendor Portal over an eight-month period using a phased implementation approach.
  • DSI's AEON Vendor Portal integrates with USPTO's existing procurement and financial systems and automates communication across systems to streamline the vendor contracting experience.

Fish & Richardson Named Most Active Law Firm at Patent Trial and Appeal Board for Fourth Consecutive Year

Monday, March 9, 2020 - 5:26pm

BOSTON, March 9, 2020 /PRNewswire/ -- Fish & Richardson has been named the most active law firm at the Patent Trial and Appeal Board (PTAB) for the fourth consecutive year according to a recent Lex Machina report that analyzedinter partes (IPR) reviews challenges filed in 2019.

Key Points: 
  • BOSTON, March 9, 2020 /PRNewswire/ -- Fish & Richardson has been named the most active law firm at the Patent Trial and Appeal Board (PTAB) for the fourth consecutive year according to a recent Lex Machina report that analyzedinter partes (IPR) reviews challenges filed in 2019.
  • Fish had more appearances than any other firm appearing in a total of 116 IPRs in 2019.
  • Since the inception of post-grant proceedings in 2012, Fish has appeared in 1,138 proceedings, far exceeding its closest competitor at the PTAB.
  • Fish & Richardson, the premier global intellectual property law firm, is trusted by the world's most innovative and influential companies.

Luxury Card Receives 51st Patent

Monday, March 9, 2020 - 9:12am

Luxury Card, a global leader in the premium credit card market, has confirmed its 51st patent for card construction technology and design.

Key Points: 
  • Luxury Card, a global leader in the premium credit card market, has confirmed its 51st patent for card construction technology and design.
  • View the full release here: https://www.businesswire.com/news/home/20200309005178/en/
    Luxury Card Receives 51st Patent (Photo: Business Wire)
    We are continually expanding on our existing designs to bring constant innovation to the metal credit card industry and are excited to achieve this [51st patent] milestone, stated Marina Kissam, Vice President of Customer Experience at Luxury Card.
  • All three state-of-the-art Luxury Card products are engineered for durability and distinctionfeatures recognized and appreciated by Luxury Card customers.
  • Luxury Card recently received its 51st patent as granted by the USPTO for a total of 30 design patents and 21 utility patents issued globally.

Farmobile Adds Blockchain to its Growing Patent Portfolio

Wednesday, March 4, 2020 - 3:00pm

LEAWOOD, Kan., March 4, 2020 /PRNewswire-PRWeb/ --Farmobile LLC, Agriculture's Independent Data Company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No.

Key Points: 
  • LEAWOOD, Kan., March 4, 2020 /PRNewswire-PRWeb/ --Farmobile LLC, Agriculture's Independent Data Company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No.
  • Farmobile is the among the first to secure a patent to use blockchain in connection with ag data licensing or sales.
  • "This is a very big deal and a significant addition to Farmobile's patent portfolio.
  • Under the patent, Farmobile retains exclusive right to use blockchain (distributed ledger technologies) to track electronic agricultural data sets based on associated transactions through the Farmobile DataStore.